1. Deng, D., Chen, X., Zhang, R., Lei, Z., Wang, X., & Zhou, F. (2021). XGraphBoost: Extracting Graph Neural Network-Based Features for a Better Prediction of Molecular Properties. Journal of Chemical Information and Modeling, 61(6), 2697–2705. https://doi.org/10.1021/ACS.JCIM.0C01489
2. Wu, Z., Ramsundar, B., Feinberg, E. N., Gomes, J., Geniesse, C., Pappu, A. S., … Pande, V. (2018). MoleculeNet: A benchmark for molecular machine learning. Chemical Science, 9(2), 513–530. https://doi.org/10.1039/c7sc02664a
3. Minnich, A. J., McLoughlin, K., Tse, M., Deng, J., Weber, A., Murad, N., … Allen, J. E. (2019). AMPL: A Data-Driven Modeling Pipeline for Drug Discovery. Retrieved from http://arxiv.org/abs/1911.05211
4. Duan, Y., Edwards, J. S., & Dwivedi, Y. K. (2019). Artificial intelligence for decision making in the era of Big Data – evolution, challenges and research agenda. International Journal of Information Management, 48, 63–71. https://doi.org/10.1016/J.IJINFOMGT.2019.01.021
5. Hussin, S. K., Abdelmageid, S. M., Alkhalil, A., Omar, Y. M., Marie, M. I., & Ramadan, R. A. (2021). Handling Imbalance Classification Virtual Screening Big Data Using Machine Learning Algorithms. Complexity, 2021. https://doi.org/10.1155/2021/6675279
6. Karim, A., Mishra, A., Newton, M. A. H., & Sattar, A. (2019). Efficient Toxicity Prediction via Simple Features Using Shallow Neural Networks and Decision Trees. ACS Omega, 4(1), 1874–1888. https://doi.org/10.1021/ACSOMEGA.8B03173
7. Mayr, A., Klambauer, G., Unterthiner, T., & Hochreiter, S. (2016). DeepTox: Toxicity Prediction using Deep Learning. Frontiers in Environmental Science, 3, 80. https://doi.org/10.3389/fenvs.2015.00080
8. PubChem. (n.d.). Retrieved October 7, 2021, from https://pubchem.ncbi.nlm.nih.gov/
9. ChemSpider | Search and share chemistry. (n.d.). Retrieved October 7, 2021, from http://www.chemspider.com/
10. Davies, M., Nowotka, M., Papadatos, G., Dedman, N., Gaulton, A., Atkinson, F., … Overington, J. P. (2015). ChEMBL web services: Streamlining access to drug discovery data and utilities. Nucleic Acids Research, 43(W1), W612–W620. https://doi.org/10.1093/NAR/GKV352
11. Merck Molecular Activity Challenge | Kaggle. (n.d.). Retrieved October 7, 2021, from https://www.kaggle.com/c/MerckActivity
12. Richard, A. M., Huang, R., Waidyanatha, S., Shinn, P., Collins, B. J., Thillainadarajah, I., … Tice, R. R. (2020). The Tox21 10K Compound Library: Collaborative Chemistry Advancing Toxicology. Chemical Research in Toxicology, 34(2), 189–216. https://doi.org/10.1021/ACS.CHEMRESTOX.0C00264
13. Unterthiner, T., Mayr, A., Klambauer, G., & Hochreiter, S. (2015). Toxicity Prediction using Deep Learning, 3(February). https://doi.org/10.3389/fenvs.2015.00080
14. Wang, Y., Xiao, J., Suzek, T. O., Zhang, J., Wang, J., Zhou, Z., … Bryant, S. H. (2012). PubChem’s BioAssay Database. Nucleic Acids Research, 40(D1), D400–D412. https://doi.org/10.1093/NAR/GKR1132
15. Ramsundar, B., Kearnes, S., Riley, P., Webster, D., Konerding, D., & Pande, V. (2015). Massively Multitask Networks for Drug Discovery.
16. Wu, Z., Ramsundar, B., Feinberg, E. N., Gomes, J., Geniesse, C., Pappu, A. S., … Pande, V. (2018). MoleculeNet: a benchmark for molecular machine learning. Chemical science, 9(2), 513–530. https://doi.org/10.1039/c7sc02664a
17. Lee, J., Yoon, W., Kim, S., Kim, D., Kim, S., So, C. H., & Kang, J. (n.d.). Data and text mining BioBERT: a pre-trained biomedical language representation model for biomedical text mining. https://doi.org/10.1093/bioinformatics/btz682
18. Devlin, J., Chang, M.-W., Lee, K., Google, K. T., & Language, A. I. (n.d.). BERT: Pre-training of Deep Bidirectional Transformers for Language Understanding.
19. Kearnes, S., McCloskey, K., Berndl, M., Pande, V., & Riley, P. (2016). Molecular Graph Convolutions: Moving Beyond Fingerprints. Journal of Computer-Aided Molecular Design, 30(8), 595–608. https://doi.org/10.1007/s10822-016-9938-8
20. Data Sources - PubChem. (n.d.). Retrieved October 7, 2021, from https://pubchem.ncbi.nlm.nih.gov/sources/#sort=Live-BioAssay-Count
21. Tox21 - PubChem Data Source. (n.d.). Retrieved October 7, 2021, from https://pubchem.ncbi.nlm.nih.gov/source/824
22. Li, J., Sun, Y., Johnson, R. J., Sciaky, D., Wei, C.-H., Leaman, R., … Lu, Z. (2016). BioCreative V CDR task corpus: a resource for chemical disease relation extraction. Database: The Journal of Biological Databases and Curation, 2016, 68. https://doi.org/10.1093/DATABASE/BAW068
23. Santos, R., Ursu, O., Gaulton, A., Patrícia Bento, A., Donadi, R. S., Bologa, C. G., … Overington, J. P. (2017). A comprehensive map of molecular drug targets. Nature Publishing Group. https://doi.org/10.1038/nrd.2016.230
24. Rogers, D., & Hahn, M. (2010). Extended-Connectivity Fingerprints. Journal of Chemical Information and Modeling, 50(5), 742–754. https://doi.org/10.1021/ci100050t
25. Keshavarzi Arshadi, A., Webb, J., Salem, M., Cruz, E., Calad-Thomson, S., Ghadirian, N., … Yuan, J. S. (2020). Artificial Intelligence for COVID-19 Drug Discovery and Vaccine Development. Frontiers in Artificial Intelligence, 3, 65. https://doi.org/10.3389/frai.2020.00065
26. Madrid, P. B., Panchal, R. G., Warren, T. K., Shurtleff, A. C., Endsley, A. N., Green, C. E., … Tanga, M. J. (2015). Evaluation of Ebola Virus Inhibitors for Drug Repurposing. https://doi.org/10.1021/acsinfecdis.5b00030
27. Schachterle, S. E., Mtove, G., Levens, J. P., Clemens, E., Shi, L., Raj, A., … Sullivan, D. J. (2014). Short-Term Malaria Reduction by Single-Dose Azithromycin during Mass Drug Administration for Trachoma, Tanzania - Volume 20, Number 6—June 2014 - Emerging Infectious Diseases journal - CDC. Emerging Infectious Diseases, 20(6), 941–949. https://doi.org/10.3201/EID2006.131302
28. Arshadi, A. K., Salem, M., Collins, J., Yuan, J. S., & Chakrabarti, D. (2020). Deepmalaria: Artificial intelligence driven discovery of potent antiplasmodials. Frontiers in Pharmacology, 10. https://doi.org/10.3389/fphar.2019.01526
29. Sagara, I., Oduro, A. R., Mulenga, M., Dieng, Y., Ogutu, B., Tiono, A. B., … Dunne, M. W. (2014). Efficacy and safety of a combination of azithromycin and chloroquine for the treatment of uncomplicated Plasmodium falciparum malaria in two multi-country randomised clinical trials in African adults. Malaria Journal 2014 13:1, 13(1), 1–10. https://doi.org/10.1186/1475-2875-13-458
30. Lamri, A., Pigeyre, M., Garver, W. S., & Meyre, D. (2018). The Extending Spectrum of NPC1-Related Human Disorders: From Niemann–Pick C1 Disease to Obesity. Endocrine Reviews, 39(2), 192. https://doi.org/10.1210/ER.2017-00176
31. K, N., A, C., K, D., DK, S., EL, H., DL, M., … RE, P. (2005). Protein transduction of Rab9 in Niemann-Pick C cells reduces cholesterol storage. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 19(11), 1558–1560. https://doi.org/10.1096/FJ.04-2714FJE
32. Giovannini, S., Weller, M.-C., Hanzlíková, H., Shiota, T., Takeda, S., & Jiricny, J. (2020). ATAD5 deficiency alters DNA damage metabolism and sensitizes cells to PARP inhibition. Nucleic Acids Research, 48(9), 4928–4939. https://doi.org/10.1093/NAR/GKAA255
33. Pensa, S., Regis, G., Boselli, D., Novelli, F., & Poli, V. (2013). STAT1 and STAT3 in Tumorigenesis: Two Sides of the Same Coin? Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK6568/
34. Chapgier, A., Wynn, R. F., Jouanguy, E., Filipe-Santos, O., Zhang, S., Feinberg, J., … Arkwright, P. D. (2006). Human Complete Stat-1 Deficiency Is Associated with Defective Type I and II IFN Responses In Vitro but Immunity to Some Low Virulence Viruses In Vivo. The Journal of Immunology, 176(8), 5078–5083. https://doi.org/10.4049/JIMMUNOL.176.8.5078
35. Richmond, J. K., & Baglole, D. J. (2003). Lassa fever: epidemiology, clinical features, and social consequences. BMJ : British Medical Journal, 327(7426), 1271. https://doi.org/10.1136/BMJ.327.7426.1271
36. Lassa fever. (n.d.). Retrieved October 7, 2021, from https://www.who.int/health-topics/lassa-fever#tab=tab_1
37. OG, G., BE, J., MR, V., WJ, V., GW, T., & HE, L. (2009). Drug targets in infections with Ebola and Marburg viruses. Infectious disorders drug targets, 9(2), 191–200. https://doi.org/10.2174/187152609787847730
38. Marburg virus disease. (n.d.). Retrieved October 7, 2021, from https://www.who.int/news-room/fact-sheets/detail/marburg-virus-disease
39. Rosenke, K., Feldmann, H., Westover, J. B., Hanley, P. W., Martellaro, C., Feldmann, F., … Safronetz, D. (2018). Use of Favipiravir to Treat Lassa Virus Infection in Macaques - Volume 24, Number 9—September 2018 - Emerging Infectious Diseases journal - CDC. Emerging Infectious Diseases, 24(9), 1696–1699. https://doi.org/10.3201/EID2409.180233
40. SL, B., TM, B., J, W., KS, W., SA, V. T., L, D., … TK, W. (2018). Efficacy of favipiravir (T-705) in nonhuman primates infected with Ebola virus or Marburg virus. Antiviral research, 151, 97–104. https://doi.org/10.1016/J.ANTIVIRAL.2017.12.021
41. Li, R., Npr, /, Wilson, B. A. P., Thornburg, C. C., Henrich, C. J., Grkovic, T., & O’keefe, B. R. (2020). Natural Product Reports Creating and screening natural product libraries, 37, 863–1032. https://doi.org/10.1039/c9np00068b
42. Early Translation Branch (ETB) | National Center for Advancing Translational Sciences. (n.d.). Retrieved October 22, 2021, from https://ncats.nih.gov/etb
43. Broad Institute. (n.d.). Retrieved October 22, 2021, from https://www.broadinstitute.org/
44. Home | SBP. (n.d.). Retrieved October 22, 2021, from https://www.sbpdiscovery.org/
45. UNM Center for Molecular Discovery | University of New Mexico flow cytometry research center. (n.d.). Retrieved October 22, 2021, from http://nmmlsc.health.unm.edu/
46. Biological Discovery through Chemical Innovation | Emory University | Atlanta GA. (n.d.). Retrieved October 22, 2021, from https://bdci.emory.edu/
47. Toxicology in the 21st Century (Tox21) | National Center for Advancing Translational Sciences. (n.d.). Retrieved October 22, 2021, from https://ncats.nih.gov/tox21
48. Lead Identification | Scripps Florida. (n.d.). Retrieved October 22, 2021, from https://hts.florida.scripps.edu/
49. Johns Hopkins Ion Channel Center - PubChem Data Source. (n.d.). Retrieved October 22, 2021, from https://pubchem.ncbi.nlm.nih.gov/source/Johns Hopkins Ion Channel Center
50. ICCB-Longwood Screening Facility. (n.d.). Retrieved October 22, 2021, from https://iccb.med.harvard.edu/
51. HMMER. (n.d.). Retrieved October 7, 2021, from http://hmmer.org/
52. and, G. W. B., & Murcko, M. A. (1996). The Properties of Known Drugs. 1. Molecular Frameworks. Journal of Medicinal Chemistry, 39(15), 2887–2893. https://doi.org/10.1021/JM9602928